Braverman’s reappointment highlights double standards over national security says Penman

The FDA has highlighted the double standards of reappointing Suella Braverman as Home Secretary less than a week after being dismissed from the same post for a security breach.
Dave Penman, FDA General Secretary, told Rajeev Syal at the Guardian that “any civil servant who had knowingly shared confidential government information… would face gross misconduct charges and in all likelihood dismissal.” Penman continued that “this is not theoretical” as civil servants have lost their security clearance and been subsequently sacked for deliberately sharing confidential information, as Braverman has admitted doing. “There rightly should be no exceptions when it comes to national security”, argued Penman.
After Braverman made an appearance in the House of Commons to address her dismissal, Penman appeared on ITV News to demonstrate how the Home Secretary’s answers failed to assuage concerns regarding the six times she sent official government documents from her personal email. Speaking to Anushka Asthana, Penman stated that is was “extraordinary that a minister would be… routinely sharing information outside of government” and he insisted that we “can’t have one rule for ministers and one rule for civil servants”.
Related News
-

FDA condemns dismissal of Sir Olly Robbins over Mandelson vetting
The FDA has condemned the Prime Minister’s dismissal of Sir Olly Robbins, former FCDO Permanent Secretary, over the vetting of Lord Mandelson for his appointment as Ambassador to the United States.
-

Never again
Following the unacceptable issues arising from the civil service pension scheme transfer to Capita, Adrian Prandle outlines the FDA’s ongoing work to ensure members get the support they need as quickly as possible.
-

Shaping the world of work: Dave Penman on the challenges facing the civil service, and plans for his new term as General Secretary
Following his re-election, Dave Penman outlines the challenges of the next five years and his plans to improve the working lives of FDA’s members.